|
|
||||||||
RESEARCH REPORTS |
1 Division of Orthodontics and Dentofacial Orthopedics, and 2 Division of Oral Dysfunction Science, Department of Oral Health and Development Sciences, Graduate School of Dentistry, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan;
* corresponsing author, kanzaki{at}mail.tains.tohoku.ac.jp
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: gene transfer osteoprotegerin tooth movement mechanical stress osteoclastogenesis
| INTRODUCTION |
|---|
|
|
|---|
To test our hypothesis, we used experimental tooth movement in rats with or without local OPG gene transfer via a hemagglutinating virus of Japan (HVJ; Sendai virus) envelope vector gene delivery system.
| MATERIALS & METHODS |
|---|
|
|
|---|
All animals were treated ethically, in compliance with the regulations of Tohoku University.
Cloning of the Mouse OPG Gene and Construction of the OPG Expression Plasmid
Total RNA was extracted from the mouse osteoblastic cell-line MC3T3-E1 by means of a QuickPrep® Total RNA extraction kit (Pharmacia Biotech, Uppsala, Sweden). The RNA was then reverse-transcribed with the use of You-Prime First Strand Beads (Pharmacia Biotech) and Oligo(dT)15 primer (Madison, WI, USA). First-strand cDNA was subjected to PCR amplification with specific PCR primers. Two primers were designed with the use of the mouse OPG cDNA plus restriction site, primer XhoI site+OPG upstream (5'-GGGCTCGAG TGAGGTTTCCCGAGGAC-3') and primer OPG downstream+XbaI site (5'-CTAGTCTAG AACAGCCCAGTGA CCATTC-3'). PCR was performed by means of a KOD-Dash DNA Polymerase-kit (Toyobo Co., Ltd., Tokyo, Japan), following the manufacturers instructions. Each cycle consisted of a heat-denaturation step at 94°C for 30 sec, an annealing step at 51°C for 2 sec, and an extension step at 74°C for 2 min. The amplified cloning plasmid vector containing the restriction-site-tagged OPG sequence was digested with both XhoI and XbaI restriction enzymes (Invitrogen, Carlsbad, CA, USA), and the insert was ligated into the linearized expression plasmid vector pcDNA3.1(+) with the use of a DNA Ligation-kit (Takara-Bio Inc., Shiga, Japan). The sequence was checked with the use of the ALFexpressTMCyTM5 Thermo SequenaseTM Dye Terminator-kit (Amersham-Biosciences, Piscataway, NJ, USA). This OPG expression vector (pcDNA-mOPG) was driven by a cytomegalovirus (CMV) promoter: the sequence-encoded functional mouse OPG (NM_008764, 70-1317 bp). Amplified pcDNA-mOPG was purified with Triton X-114 for removal of bacterial endotoxin.
In vitro Assay of the Constructed OPG Expression Plasmid
The constructed OPG expression plasmid was transfected into NIH3T3 cells with the use of Lipofectamine Plus (Invitrogen Corporation, Carlsbad, CA, USA). At 72 hrs after transfection, total RNA, culture media, and whole protein were collected. From the total RNA, the delivery of the OPG gene was checked by RT-PCR. From the culture media and whole protein, OPG production was checked by Western blot analysis with the use of anti-OPG antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The functional activity of the OPG was tested with a bone-resorption assay. Briefly, we performed the bone-resorption assay by culturing cells on calcium-phosphate-coated discs (Osteologic®, BD Biosciences, Kingston, ON, Canada). Rat bone-marrow cells were collected (Scheven et al., 1986), seeded on Osteologic® discs, and cultured in D-MEM containing 10%FBS (Biocell Laboratories, Rancho Dominguez, CA, USA) supplemented with 1,25-(OH)2D3 (1 x 108 M) with or without 50% of collected culture media. Medium was changed every 5 days throughout the experiment. After cultivation for 21 days, the discs were cleaned with a trypsin-EDTA solution. Photographs were taken and scanned with a Minolta Dimage-ScanDual (Minolta, Ramsey, NJ, USA). The areas of resorption pits from randomly selected fields were measured with the use of ScionImage® (Scion Co., Frederick, MD, USA) for Windows®.
In vivo Gene Transfer
For in vivo transfection, we used an HVJ-envelope-vector kit (GenomONE®, Ishihara-sangyo kaisha Ltd., Osaka, Japan), according to the manufacturers instructions (Kaneda et al., 2002). Administration of the HVJ-envelope-vector containing pcDNA-mOPG to the animals in the OPG-transfection group was started on the initial day of force application. A 5-µL quantity of vector-solution was injected into the sub-periosteal area, adjacent to the first molars, on days 0, 3, 7, 10, 14, and 17 of the experiment, with the animals under anesthesia (Fig. 1a
). The animals in the tooth-movement group were injected with 5 µL of PBS in the corresponding area.
|
Measurement of Bone Mineral Density (BMD) of Tibiae
After the death of the experimental animals, their bilateral tibiae were excised, and the soft tissues were removed. Lateral radiographs of tibiae were taken along with hydroxyapatite standards, by means of a soft x-ray apparatus (Sohuron Inc., Tokyo, Japan) set at 5 mA, 40 cm, 40 sec, and 30 kV. The densitometric patterns of the proximal tibiae, especially the cancellous bone area, were measured by ScionImage® (Fig. 1c
).
Cytochemical Examinations
Animals were killed under pentobarbital anesthesia on day 21, and the tissues were fixed by perfusion with 4% paraformaldehyde in PBS. The upper jaw, including the molars, was dissected and further fixed overnight. Specimens were then decalcified with 10% ethylenediamine-tetraacetic acid in 0.01 M PBS (pH 7.4) for 9 wks at 4°C, dehydrated, and embedded in paraffin. Periodontal tissues from the mesiopalatal roots of the upper first molars were examined in serial cross-sections of the molars at the bifurcation level. TRAP staining of the sections (8 µm thick) was performed with a Leukocyte Acid-Phosphatase kit (Sigma-Diagnostics®, St. Louis, MO, USA) for osteoclast detection. We counted the TRAP-positive multinucleated cells that formed resorption lacunae on the alveolar bone surface adjacent to the mesiopalatal roots of the upper first molars.
Immunohistochemical Analysis
In brief, the sections were deparaffinized, pre-incubated in 5% bovine serum albumin (Dako, Glostrup, Denmark) in PBS for 30 min, and subsequently incubated with anti-OPG antibody (1:250 dilution; sc-8468; Santa Cruz Biotechnology) overnight at 4°C. After being thoroughly rinsed, the sections were incubated with the FITC-conjugated anti-goat IgG (1:1000 dilution; sc-2024; Santa Cruz Biotechnology), washed, mounted in PBS-glycerol, and observed with a fluorescence microscope (Leica, Heidelberg, Germany).
Statistics
Data were analyzed for statistical differences by Kruskal-Wallis analysis, followed by a Bonferroni-type multiple comparison (Tukey type). Differences with P < 0.05 were considered significant. The values are expressed as the means ± SD.
| RESULTS |
|---|
|
|
|---|
In addition, local gene transfer did not affect the bone mineral density (BMD) of tibiae (Fig. 1d
). The average BMDs of rats in the tooth-movement and OPG-transfection groups were 1609 µg/mm2 (SD = 58.5) and 1643 µg/mm2 (SD = 56.7), respectively.
In vitro Assay of the Constructed OPG Expression Plasmid
After construction of the OPG expression plasmid, we assessed the function of protein produced in vitro. OPG gene delivery and OPG production in transfected cells were confirmed (Figs. 2a
, 2b
). Furthermore, we performed a resorption assay to determine whether the OPG produced was functionally intact (Figs. 2c
, 2d
). Rat bone marrow cells cultured with 1,25-(OH)2D3 differentiated into osteoclasts, and there were many resorbed areas (18.3 ± 3.1%) (Fig. 2d
, control). However, when the medium collected from transfected cell cultures was added, osteoclastic resorption was obviously inhibited. The resorbed area of transfected samples was almost one-third that of control samples (6.2 ± 1.9%) (Fig. 2d
, transfected).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Numerous reports have described the pharmacological control of tooth movement through the regulation of osteoclasts. Non-steroidal anti-inflammatory drugs inhibit cyclooxygenase and result in delayed tooth movement (Chumbley and Tuncay, 1986; Kehoe et al., 1996; Roche et al., 1997). However, because these drugs are rapidly flushed by blood circulation, daily systemic administration or daily local injection is needed. Others have used bisphosphonates to control orthodontic tooth movement (Igarashi et al., 1994; Kim et al., 1999). Bisphosphonates tend to incorporate into bone tissue and directly inactivate osteoclasts; this treatment requires injection every 3 days (Adachi et al., 1994). Collins and Sinclair tested the effect of vitamin D3 on tooth movement. They found that vitamin D3 activated osteoclasts and observed rapid tooth movement (Collins and Sinclair, 1988). The local administration of prostaglandins (Lee, 1990), osteocalcin (Hashimoto et al., 2001), or PTH (Soma et al., 2000) also induced orthodontic tooth movement. In this study, we used local OPG gene transfer instead of OPG administration. Local gene transfer has two advantages (Blesing and Kerr, 1996): First, it can maintain a locally effective concentration and prolonged protein expression, regardless of blood circulation. Second, protein expression occurs at the local site, so that systemic effects are avoided. However, because recurrent injection of viral membrane to the experimental animals could induce immune responses, further modifications of gene transfer are required.
We were able to induce local OPG expression in the periodontal tissue without any systemic effects (Figs. 1b
, 1d
). However, OPG induction was not limited to the palatal sides of the first molars; OPG was also slightly increased on the buccal sides (Fig. 3d
). There are two possible explanations for this: First, the vector solution might have diffused due to blood flow. Second, because the OPG protein produced from the pcDNA-mOPG gene is soluble, it might have diffused via the interstitial fluid.
Local OPG gene transfer significantly inhibited the osteoclastogenesis in the periodontium that was caused by experimental tooth movement (Figs. 4a
4c
). The number of osteoclasts in the OPG-gene-transfer group was about half that in the tooth-movement group. Thus, OPG gene transfer did not completely inhibit the induction of osteoclastogenesis. The partial inhibition may have been due to a low efficiency of transfection; alternatively, osteoclastogenesis induction by orthodontic tooth movement may be controlled, in part, by other cytokines, such as vascular endothelial growth factor (VEGF) (Kaku et al., 2001; Kohno et al., 2003), IL-1 (Saito et al., 1991; Alhashimi et al., 2001; Iwasaki et al., 2001), and TNF-
(Lowney et al., 1995; Lossdorfer et al., 2002).
Enforced OPG expression diminished tooth movement to almost half that observed in the tooth-movement group on day 21 (Figs. 4d
, 4e
). The tooth movement that occurred in the OPG-transfection group may have been the result of induced RANKL expression that was not completely inhibited by OPG gene transfer; alternatively, orthodontic tooth movement may also be controlled by other cytokines, as described above.
In this study, we demonstrated that OPG gene transfer to the periodontal tissue inhibited RANKL-mediated osteoclastogenesis induced by mechanical stress, and inhibited experimental tooth movement, without eliciting any systemic effects. In conclusion, osteoclastogenesis in response to orthodontic tooth movement appears to be regulated primarily through RANKL signaling in periodontal cells.
| ACKNOWLEDGMENTS |
|---|
Received November 6, 2003; Last revision September 5, 2004; Accepted September 28, 2004
| REFERENCES |
|---|
|
|
|---|
Alhashimi N, Frithiof L, Brudvik P, Bakhiet M (2001). Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. Am J Orthod Dentofacial Orthop 119:307312.[ISI][Medline]
Blesing CH, Kerr DJ (1996). Intra-hepatic arterial drug delivery. J Drug Target 3:341347.[ISI][Medline]
Brudvik P, Rygh P (1994). Multi-nucleated cells remove the main hyalinized tissue and start resorption of adjacent root surfaces. Eur J Orthod 16:265273.
Chumbley AB, Tuncay OC (1986). The effect of indomethacin (an aspirin-like drug) on the rate of orthodontic tooth movement. Am J Orthod 89:312314.[ISI][Medline]
Collins MK, Sinclair PM (1988). The local use of vitamin D to increase the rate of orthodontic tooth movement. Am J Orthod Dentofacial Orthop 94:278284.[ISI][Medline]
Davidovitch Z (1988). Neurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics. Dent Clin North Am 32:411435.
Hashimoto F, Kobayashi Y, Mataki S, Kobayashi K, Kato Y, Sakai H (2001). Administration of osteocalcin accelerates orthodontic tooth movement induced by a closed coil spring in rats. Eur J Orthod 23:535545.
Igarashi K, Mitani H, Adachi H, Shinoda H (1994). Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats. Am J Orthod Dentofacial Orthop 106:279289.[ISI][Medline]
Iwasaki LR, Haack JE, Nickel JC, Reinhardt RA, Petro TM (2001). Human interleukin-1 beta and interleukin-1 receptor antagonist secretion and velocity of tooth movement, Arch Oral Biol 46:185189.[ISI][Medline]
Kaku M, Kohno S, Kawata T, Fujita I, Tokimasa C, Tsutsui K, et al. (2001). Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice. J Dent Res 80:18801883.
Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, et al. (2002). Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6:219226.[ISI][Medline]
Kanzaki H, Chiba M, Shimizu Y, Mitani H (2002). Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappa B ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res 17:210220.[ISI][Medline]
Kehoe MJ, Cohen SM, Zarrinnia K, Cowan A (1996). The effect of acetaminophen, ibuprofen, and misoprostol on prostaglandin E2 synthesis and the degree and rate of orthodontic tooth movement, Angle Orthod 66:339349.[ISI][Medline]
Kim TW, Yoshida Y, Yokoya K, Sasaki T (1999). An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. Am J Orthod Dentofacial Orthop 115:645653.[ISI][Medline]
Kohno S, Kaku M, Tsutsui K, Motokawa M, Ohtani J, Tenjo K, et al. (2003). Expression of vascular endothelial growth factor and the effects on bone remodeling during experimental tooth movement. J Dent Res 82:177182.
Lee WC (1990). Experimental study of the effect of prostaglandin administration on tooth movementwith particular emphasis on the relationship to the method of PGE1 administration. Am J Orthod Dentofacial Orthop 98:231241.[ISI][Medline]
Lossdorfer S, Gotz W, Jager A (2002). Localization of IL-1alpha, IL-1 RI, TNF, TNF-RI and TNF-RII during physiological drift of rat molar teethan immunohistochemical and in situ hybridization study. Cytokine 20:716.[ISI][Medline]
Lowney JJ, Norton LA, Shafer DM, Rossomando EF (1995). Orthodontic forces increase tumor necrosis factor alpha in the human gingival sulcus. Am J Orthod Dentofacial Orthop 108:519524.[ISI][Medline]
Oshiro T, Shiotani A, Shibasaki Y, Sasaki T (2002). Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec 266:218225.[Medline]
Roberts WE, Goodwin WC, Heiner SR (1981). Cellular response to orthodontic force. Dent Clin North Am 25:317.[ISI][Medline]
Roche JJ, Cisneros GJ, Acs G (1997). The effect of acetaminophen on tooth movement in rabbits. Angle Orthod 67:231236.[ISI][Medline]
Saito M, Saito S, Ngan PW, Shanfeld J, Davidovitch Z (1991). Interleukin 1 beta and prostaglandin E are involved in the response of periodontal cells to mechanical stress in vivo and in vitro. Am J Orthod Dentofacial Orthop 99:226240.[ISI][Medline]
Saitoh S, Takahashi I, Mizoguchi I, Sasano Y, Kagayama M, Mitani H (2000). Compressive force promotes chondrogenic differentiation and hypertrophy in midpalatal suture cartilage in growing rats. Anat Rec 260:392401.[Medline]
Scheven BA, Visser JW, Nijweide PJ (1986). In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321:7981.[Medline]
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell 89:309319.[ISI][Medline]
Soma S, Matsumoto S, Higashi Y, Takano-Yamamoto T, Yamashita K, Kurisu K, et al. (2000). Local and chronic application of PTH accelerates tooth movement in rats, J Dent Res 79:17171724.
Storey E (1973). The nature of tooth movement. Am J Orthod 63:292314.[ISI][Medline]
Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, et al. (1999). Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 25:517523.[Medline]
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, et al. (1999). A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25:109113.[Medline]
This article has been cited by other articles:
![]() |
G.E. Wise and G.J. King Mechanisms of Tooth Eruption and Orthodontic Tooth Movement J. Dent. Res., May 1, 2008; 87(5): 414 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaguchi, N. Aihara, T. Kojima, and K. Kasai RANKL Increase in Compressed Periodontal Ligament Cells from Root Resorption. J. Dent. Res., August 1, 2006; 85(8): 751 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
Relevant research from non-orthodontic journals J. Orthod., June 1, 2005; 32(2): 142 - 144. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |